TY  - JOUR 
AU  - Martínez Pías, Enrique
AU  - Guerrero Peral, Angel Luis
AU  - Sierra, Álvaro
AU  - Trigo, Javier
AU  - García Azorín, David
PY  - 2021
UR  - https://uvadoc.uva.es/handle/10324/59548
AB  - OnabotulinumtoxinA is one of the main preventive treatments for chronic migraine. Despite that up to one third of patients with chronic migraine suffer from daily headache, these individuals have hardly been studied. We conducted a prospective cohort...
LA  - eng
PB  - MDPI
KW  - Neurology
KW  - Internal Medicine
KW  - Botulinum toxin type A
KW  - Headache disorders
KW  - Migraine
KW  - Toxina botulínica tipo A
KW  - Trastornos de cefalea
KW  - Migraña
TI  - Daily headache in chronic migraine Is a predictive factor of response in patients who had completed three sessions of OnabotulinumtoxinA
DO  - 10.3390/toxins13060432
ER  -